SCHEMBL10126547

SCHEMBL10126547

Nc1ccc(F)c(C(=O)N2CCCCC2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.59
HPGD P15428 5/20 0.54
CNR1 P21554 3/20 0.49
HTT P42858 1/20 0.49
KDM4E B2RXH2 2/20 0.49
LMNA P02545 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
ALOX15 P16050 1/20 0.46
GFER P55789 1/20 0.46
YWHAG P61981 1/20 0.46
HSD17B10 Q99714 1/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 2/20 0.46
PARP1 P09874 1/20 0.45
CPS1 P31327 1/20 0.44
PIK3CA P42336 1/20 0.44
MTOR P42345 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4724651 0.85 CPS1 (0.56) TSHRHPGDCNR1KDM4ELMNA
SCHEMBL3400169 0.84 MEN1 (0.57) TSHRLMNAMEN1KMT2AALOX15
SCHEMBL1392181 0.84 MAPT (0.57) TSHRCNR1HTTKDM4EMAPT
SCHEMBL29944128 0.83 TSHR (0.62) TSHRHPGDCNR1LMNAMEN1
SCHEMBL17774874 0.82 HSP90AA1 (0.55) HPGDHTTKDM4ELMNAMEN1
SCHEMBL12636528 0.81 TSHR (0.59) TSHRHPGDCNR1HTTKDM4E
SCHEMBL10126592 0.81 HPGD (0.54) TSHRHPGDHTTKDM4EMEN1
SCHEMBL3899778 0.81 HTT (0.60) TSHRHPGDHTTKDM4ELMNA
SCHEMBL22767344 0.81 HPGD (0.58) TSHRHPGDHTTKDM4ELMNA
SCHEMBL29451263 0.81 HPGD (0.54) TSHRHPGDHTTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 TSHR 3964/4885HPGD 4520/4885CNR1 1904/4885
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 TSHR 3964/4885HPGD 4520/4885CNR1 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.